Glaxo and Pfizer Form HIV Venture, But A Spin-Off Could Be In The Wings

In a bid to patch over their respective weaknesses in the HIV marketplace, GlaxoSmithKline and Pfizer announced April 16 they are forming a jointly owned company combining their portfolios of existing and developing drugs